Efficacy and Safety of ACH24 in the Treatment of Vitiligo

NCT01419964 · clinicaltrials.gov ↗
PHASE3
Phase
WITHDRAWN
Status
INDUSTRY
Sponsor class

Stopped The Brazilian regulatory agency - ANVISA has requested the cancellation of the phase 3 study for conducting a phase 1 study first.

Conditions

Interventions

Sponsor

Ache Laboratorios Farmaceuticos S.A.